Morningstar Investor users sign in here.

Company Profile

  • Business description

    PYC Therapeutics Ltd is an RNA therapeutics drug development company, leveraging a proprietary delivery platform to solve the challenges in RNA therapeutics - safe and effective delivery of the drug inside the cell. The company's principal business activity is of of drug development and progressing the company’s drug pipeline through preclinical and clinical development. Geographically, it operates only in Australia.

  • Contact

    6 Verdun Street
    Harry Perkins Institute of Medical Research
    Nedlands
    Perth WA 6009
    AUS

    T: +61 861510992

    https://www.pyctx.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 June 2024

    Employees

    5

Stocks News & Analysis

stocks

3 ASX shares to avoid

These shares have surged in price in the last year but are significantly overvalued according to our analysts. 
stocks

How to find companies that can grow forever

If you want to find companies with a long growth runway, try looking for these seven attributes.
stocks

2 undervalued ASX shares where headline issues mask underlying value

These two companies with moat may represent an opportunity for long-term investors.

Markets

Index
Last price
Change
% Change
All Ordinaries 8,076.70 11.20 0.14%
CAC 40 8,131.41 55.73 0.69%
DAX 40 18,498.38 68.33 0.37%
Dow JONES (US) 38,943.23 58.97 0.15%
FTSE 100 8,354.05 40.38 0.49%
HKSE 18,313.86 165.51 -0.90%
NASDAQ 16,281.15 51.40 -0.31%
Nikkei 225 38,202.37 632.73 -1.63%
NZX 50 Index 11,782.89 17.89 -0.15%
S&P 500 5,180.23 7.47 -0.14%
S&P/ASX 200 7,804.50 11.20 0.14%
SSE Composite Index 3,128.48 19.26 -0.61%

Market Movers

We’re currently having some problems with our data feed. We apologise for any inconvenience.